Illinois Municipal Retirement Fund’s Cytek Biosciences CTKB Stock Holding History

Illinois Municipal Retirement Fund’s Portfolio CTKB Stock Details CTKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$266K	Buy	+60,877	New	+$287K	﹤0.01%	1119

Other funds holding CTKB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Illinois Municipal Retirement Fund's CTKB Position: Q1 2026 in Review

Illinois Municipal Retirement Fund opened a new position in Cytek Biosciences (CTKB) in Q1 2026: 60,877 shares worth $266K. The stake represents ﹤0.01% of the portfolio and ranks #1119 among its holdings.

165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

Illinois Municipal Retirement Fund held 60,877 shares of Cytek Biosciences worth $266K as of Q1 2026.
Cytek Biosciences was a new Illinois Municipal Retirement Fund position in Q1 2026.
Cytek Biosciences made up ﹤0.01% of Illinois Municipal Retirement Fund's portfolio in Q1 2026, its #1119 holding.
165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on Illinois Municipal Retirement Fund's 13F filing for Q1 2026, filed 5 May 2026.